Acutaas Chemicals Ltd (ACUTAAS) Q2FY27 Management Mirror - Sep-2026 Qtr
FY27 EBITDA Margin Guidance Upgraded to 38%-40% in Sep'26 Qtr From 34.5%-36% Guided in Mar'26 Qtr
H1 FY27 EBITDA margin reached 37.7% and Q2 FY27 expanded to 40.3%, as reported in Sep'26 Qtr results. In the Mar'26 and Jun'26 Qtr concalls, management had initially guided for full-year FY27 EBITDA margins to remain stable at FY26 levels of around 34.5% to 36%. Tracking ahead of this expectation, management upgraded its FY27 EBITDA margin guidance to a range of 38% to 40% in the Sep'26 Qtr concall. This upgraded outlook is supported by a higher product mix contribution from the high-margin CDMO segment and operating leverage as production scales across facilities.
4 more themes on the ELITE plan.